Coloplast A/S (CLPBF)
USD 112.54
(0.0%)
USD 112.54
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | 8.48 Billion DKK | 9.67% |
| 2023 | 7.73 Billion DKK | -1.7% |
| 2022 | 7.22 Billion DKK | 8.72% |
| 2021 | 7.05 Billion DKK | 12.24% |
| 2020 | 6.34 Billion DKK | 3.72% |
| 2019 | 6.21 Billion DKK | 11.78% |
| 2018 | 5.64 Billion DKK | 0.67% |
| 2017 | 5.57 Billion DKK | 3.53% |
| 2016 | 4.61 Billion DKK | 6.64% |
| 2015 | 1.73 Billion DKK | 9.38% |
| 2014 | 3.62 Billion DKK | 11.54% |
| 2013 | 4.16 Billion DKK | 7.95% |
| 2012 | 3.79 Billion DKK | 20.39% |
| 2011 | 3.15 Billion DKK | 17.47% |
| 2010 | 2.6 Billion DKK | 33.92% |
| 2009 | 2 Billion DKK | 15.63% |
| 2008 | 1.73 Billion DKK | 7.04% |
| 2007 | 1.81 Billion DKK | 23.76% |
| 2006 | 1.24 Billion DKK | -7.56% |
| 2005 | 1.34 Billion DKK | 25.19% |
| 2004 | 1.13 Billion DKK | -23.88% |
| 2003 | 1.48 Billion DKK | -16.23% |
| 2002 | 1.77 Billion DKK | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 1.99 Billion DKK | 7.03% |
| 2024 Q3 | 2.18 Billion DKK | 4.17% |
| 2024 Q2 | 2.09 Billion DKK | -0.99% |
| 2023 FY | - DKK | -1.7% |
| 2023 Q2 | 1.98 Billion DKK | 7.6% |
| 2023 Q1 | 1.84 Billion DKK | -8.91% |
| 2023 Q4 | 2 Billion DKK | 0.91% |
| 2023 Q3 | 1.98 Billion DKK | 0.25% |
| 2022 Q1 | 1.81 Billion DKK | -2.84% |
| 2022 FY | - DKK | 8.72% |
| 2022 Q4 | 2.02 Billion DKK | -3.76% |
| 2022 Q3 | 2.1 Billion DKK | 6.49% |
| 2022 Q2 | 1.97 Billion DKK | 8.83% |
| 2021 FY | - DKK | 12.24% |
| 2021 Q1 | 1.69 Billion DKK | 6.36% |
| 2021 Q2 | 1.96 Billion DKK | 16.39% |
| 2021 Q3 | 1.84 Billion DKK | -6.2% |
| 2021 Q4 | 1.86 Billion DKK | 1.08% |
| 2020 Q4 | 1.58 Billion DKK | 0.38% |
| 2020 Q3 | 1.58 Billion DKK | -10.11% |
| 2020 Q1 | 1.66 Billion DKK | 2.71% |
| 2020 FY | - DKK | 3.72% |
| 2020 Q2 | 1.76 Billion DKK | 5.51% |
| 2019 Q3 | 1.6 Billion DKK | 4.77% |
| 2019 FY | - DKK | 11.78% |
| 2019 Q1 | 1.47 Billion DKK | -3.22% |
| 2019 Q2 | 1.53 Billion DKK | 3.94% |
| 2019 Q4 | 1.62 Billion DKK | 1.31% |
| 2018 FY | - DKK | 0.67% |
| 2018 Q1 | 1.34 Billion DKK | -7.94% |
| 2018 Q4 | 1.52 Billion DKK | 5.62% |
| 2018 Q3 | 1.44 Billion DKK | 3.37% |
| 2018 Q2 | 1.39 Billion DKK | 3.64% |
| 2017 Q4 | 1.46 Billion DKK | 5.11% |
| 2017 Q3 | 1.39 Billion DKK | -0.79% |
| 2017 Q1 | 1.34 Billion DKK | -3.6% |
| 2017 FY | - DKK | 3.53% |
| 2017 Q2 | 1.4 Billion DKK | 4.55% |
| 2016 FY | - DKK | 6.64% |
| 2016 Q2 | 1.29 Billion DKK | 1.25% |
| 2016 Q3 | 1.33 Billion DKK | 2.78% |
| 2016 Q1 | 1.28 Billion DKK | -7.17% |
| 2016 Q4 | 1.39 Billion DKK | 4.28% |
| 2015 Q3 | 1.19 Billion DKK | -6.63% |
| 2015 FY | - DKK | 9.38% |
| 2015 Q1 | 1.18 Billion DKK | -2.86% |
| 2015 Q2 | 1.28 Billion DKK | 7.82% |
| 2015 Q4 | 1.38 Billion DKK | 15.29% |
| 2014 Q1 | 1.11 Billion DKK | 4.22% |
| 2014 Q3 | 1.16 Billion DKK | 5.32% |
| 2014 FY | - DKK | 11.54% |
| 2014 Q4 | 1.22 Billion DKK | 4.7% |
| 2014 Q2 | 1.11 Billion DKK | -0.09% |
| 2013 Q1 | 1 Billion DKK | -0.69% |
| 2013 FY | - DKK | 7.95% |
| 2013 Q4 | 1.06 Billion DKK | -0.84% |
| 2013 Q3 | 1.07 Billion DKK | 7.39% |
| 2013 Q2 | 1 Billion DKK | -0.2% |
| 2012 Q3 | 1.04 Billion DKK | 14.25% |
| 2012 Q4 | 1.01 Billion DKK | -3.07% |
| 2012 Q2 | 912 Million DKK | 9.48% |
| 2012 FY | - DKK | 20.39% |
| 2012 Q1 | 833 Million DKK | -6.09% |
| 2011 Q2 | 708 Million DKK | -6.84% |
| 2011 Q1 | 760 Million DKK | -1.3% |
| 2011 FY | - DKK | 17.47% |
| 2011 Q3 | 799 Million DKK | 12.85% |
| 2011 Q4 | 887 Million DKK | 11.01% |
| 2010 Q1 | 597 Million DKK | 6.23% |
| 2010 FY | - DKK | 33.92% |
| 2010 Q4 | 770 Million DKK | 14.58% |
| 2010 Q3 | 672 Million DKK | 4.02% |
| 2010 Q2 | 646 Million DKK | 8.21% |
| 2009 Q2 | 507 Million DKK | 0.0% |
| 2009 Q1 | 507 Million DKK | 0.0% |
| 2009 FY | - DKK | 15.63% |
| 2009 Q4 | 562 Million DKK | 14.93% |
| 2009 Q3 | 489 Million DKK | -3.55% |
| 2008 FY | - DKK | 7.04% |
| 2007 FY | - DKK | 23.76% |
| 2006 FY | - DKK | -7.56% |
| 2005 FY | - DKK | 25.19% |
| 2004 FY | - DKK | -23.88% |
| 2003 FY | - DKK | -16.23% |
| 2002 FY | - DKK | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| American Medical Technologies Inc. | -963.95 Thousand USD | 879810.028% |
| Ansell Limited | 209.86 Million USD | -3940.764% |
| Ansell Limited | 206.3 Million USD | -4010.519% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 42.83 Million USD | -19694.676% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | -1.62 Million USD | 521961.89% |
| Psykey, Inc. | -1.29 Million USD | 654772.571% |
| ConvaTec Group Plc | 455.5 Million USD | -1761.69% |
| ConvaTec Group Plc | 455.5 Million USD | -1761.69% |
| Encision Inc. | -544.19 Thousand USD | 1558364.96% |
| Golden Valley Development, Inc | -141.81 Thousand USD | 5979932.17% |
| Hear AtLast Holdings, Inc. | -109.93 Thousand USD | 7714099.818% |
| Innovative MedTech Inc. | -7.67 Million USD | 110605.632% |
| LifePoint, Inc. | -14.2 Million USD | 59809.324% |
| Medite Cancer Diagnostics, Inc. | -6.18 Million USD | 137161.581% |
| Paradigm Medical Industries, Inc. | -325 Thousand USD | 2609330.769% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | -215.23 Thousand USD | 3939997.972% |
| Reflect Scientific, Inc. | -405.78 Thousand USD | 2089881.756% |
| SmileDirectClub, Inc. | -186.13 Million USD | 4655.735% |
| Sector 10, Inc. | - USD | -Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 447.82 Million USD | -1793.599% |
| SheerVision, Inc. | -110.53 Thousand USD | 7672155.803% |
| United Health Products, Inc. | -2.5 Million USD | 338999.87% |
| Vasamed, Inc. | -4.57 Million USD | 185477.801% |
| Wearable Health Solutions, Inc. | -2.26 Million USD | 375199.083% |
| Yubo International Biotech Limited | -1.17 Million USD | 720156.11% |